YI
111, Inc.
NASDAQ · CNHealthcareMedical - Pharmaceuticals
$3.94+8.54%
Price as of Jul 20, 2026
YI profitability
111, Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 5.7%
- EBITDA margin
- -0.1%
- EBIT margin
- -0.2%
- Net margin
- -0.7%
- Free cash flow margin
- -0.8%
Returns
- Return on equity
- 70.4%
- Return on assets
- -26.9%
- Return on invested capital
- 40.7%
- Asset turnover
- 9.14x
Cash efficiency
- Cash from operations
- -$12.6M
- Cash per share
- $0.89
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.